ORIC Pharmaceuticals, a privately held, clinical-stage oncology company, announced Dr. Christian Kuhlen has been named general counsel.

Dr. Kuhlen will serve on the executive leadership team and lead ORIC’s legal, compliance, intellectual property, and corporate governance functions.

Most recently, Dr. Kuhlen served as general counsel and secretary for Synthorx, where he led the legal aspects of its initial public offering and advised on the company’s subsequent acquisition by Sanofi.

Topics